Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
Post Approval Study 2: Hintermann Series H3 Total Ankle Replacement System
Sponsor: DT MedTech, LLC
This NA trial investigates Osteoarthritis Ankle and Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder) and is currently actively recruiting participants. DT MedTech, LLC leads this study, which shows 10 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
-
Feb 2024 — Apr 2024 [monthly]
Recruiting NA
-
Aug 2023 — Feb 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Apr 2023 — Aug 2023 [monthly]
Recruiting NA
-
Mar 2023 — Apr 2023 [monthly]
Recruiting NA
-
Jul 2022 — Mar 2023 [monthly]
Recruiting NA
-
Mar 2022 — Jul 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Mar 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- DT MedTech, LLC
For direct contact, visit the study record on ClinicalTrials.gov .